Spectrum of movement disorders associated with glutaric aciduria type 1: A study of 16 patients

Movement Disorders

Volumn 23, Issue 16, 2008, Pages 2392-2397

  Gitiaux, Cyril ^a   Roze, Emmanuel ^b,c,m   Kinugawa, Kiyoka ^b   Flamand Rouvière, Constance ^d   Boddaert, Nathalie ^a,e   Apartis, Emmanuelle ^f   Valayannopoulos, Vassili ^a   Touati, Guy ^a   Motte, Jacques ^g   Devos, David ^h   Mention, Karine ⁱ   Dobbelaere, Dries ⁱ   Rodriguez, Diana ^c   Roubertie, Agathe ^j   Chabrol, Brigitte ^k   Feillet, François ^l   Vidailhet, Marie ^b,c   Bahi Buisson, Nadia ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Groupe Hospitalier Piné Salpêtrieè   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Service de Neurologie   (France)

^e DIF   (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g AMERICAN MEMORIAL HOSPITAL   (France)

^h IFR 114   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j HÔpital Gui de Chauliac   (France)

^k TIMONE HOSPITAL   (France)

^l INSERM   (France)

^m PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

Development; Dystonia; Metabolic disease; Speech disorder; Striatum

Indexed keywords

GLUTARYL COENZYME A DEHYDROGENASE;

ACIDURIA; AGING; APRAXIA; ARTICLE; ATHETOSIS; CHILD; CHOREA; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DYSARTHRIA; DYSTONIA; ENZYME DEFICIENCY; FEMALE; GLUTARIC ACIDURIA TYPE 1; HUMAN; MALE; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; OROFACIAL DYSKINESIA; PARKINSONISM; PRIORITY JOURNAL; SCHOOL CHILD; SPEECH DISORDER;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MOVEMENT DISORDERS; MULTIPLE ACYL COENZYME A DEHYDROGENASE DEFICIENCY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 61449168119     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22313     Document Type: Article

References (28)

1. Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC. Glutaric aciduria; a "new" disorder of amino acid metabolism. Biochem Med 1975; 12:12-21.
2. Biery BJ, Stein DE, Morton DH, Goodman SI. Gene structure and mutations of glutaryl-coenzyme A dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. Am J Hum Genet 1996;59:1006-1011.
3. Kolker S, Koeller DM, Okun JG, Hoffmann GF. Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 2004;55:7-12.
4. Kyllerman M, Skjeldal OH, Lundberg M, et al. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord 1994;9:22-30.
5. Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT. Glutaric aciduria type I: outcome in the Republic of Ireland. J Inherit Metab Dis 2004;27:917-920.
6. Kyllerman M, Skjeldal O, Christensen E, et al. Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neurol 2004;8:121-129.
7. Busquets C, Merinero B, Christensen E, et al. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 2000;48:315-322.
8. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 2003;121:38-52.
9. Kolker S, Garbade SF, Greenberg CR, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 2006;59:840-847.
10. Gascon GG, Ozand PT, Brismar J. Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations. Brain Dev 1994;16:94-103.
11. Kolker S, Christensen E, Leonard JV, et al. Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 2007;30: 5-22.
12. Christensen E, Ribes A, Merinero B, Zschocke J. Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2004;27:861-868.
13. Neumaier-Probst E, Harting I, Seitz A, Ding C, Kolker S. Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 2004;27:869-876.
14. Twomey EL, Naughten ER, Donoghue VB, Ryan S. Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 2003;33:823-830.
15. Funk CB, Prasad AN, Frosk P, et al. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 2005;128(Part 4):711-722.
16. Hoffmann GF, Athanassopoulos S, Burlina AB, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 1996; 27:115-123.
17. Anikster Y, Shaag A, Joseph A, et al. Glutaric aciduria type I in the Arab and Jewish communities in Israel. Am J Hum Genet 1996;59:1012-1018.
18. Burlina AP, Zara G, Hoffmann GF, Zschocke J, Burlina AB. Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options. J Inherit Metab Dis 2004;27:911-915.
19. Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006;129(Part 5):1201-1217.
20. Roze E, Paschke E, Lopez N, et al. Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 2005;20:1366-1369.
21. Funk CB, Prasad AN, Del Bigio MR. Preliminary attempts to establish a rat model of striatal injury in glutaric acidaemia type I. J Inherit Metab Dis 2004;27:819-824.
22. Superti-Furga A, Hoffmann GF. Glutaric aciduria type 1 (glutaryl-CoA-dehydrogenase deficiency): advances and unanswered questions. Report from an international meeting. Eur J Pediatr 1997;156:821-828.
23. Koeller DM, Sauer S, Wajner M, et al. Animal models for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2004;27:813-818.
24. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 1993;16:125-131.
25. Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 1993;61:1147-1150.
26. Caer M, Viala K, Levy R, et al. Adult-onset chorea and mitochondrial cytopathy. Mov Disord 2005;20:490-492.
27. Orcesi S, Gorni K, Termine C, et al. Bilateral putaminal necrosis associated with the mitochondrial DNA A8344G myoclonus epilepsy with ragged red fibers (MERRF) mutation: an infantile case. J Child Neurol 2006;21:79-82.
28. Piao YS, Tang GC, Yang H, Lu DH. Clinico-neuropathological study of a Chinese case of familial adult Leigh syndrome. Neuropathology 2006;26:218-221.